Abeona Therapeutics Inc vs SiTime Corporation — how do they compare? Abeona Therapeutics Inc trades at $7.43 (market cap $421.19M), while SiTime Corporation trades at $709.34 (market cap $20.05B). The key difference: SiTime Corporation is far larger — about 47.6× Abeona Therapeutics Inc's market cap, and Abeona Therapeutics Inc is trading nearer its 52-week high, SiTime Corporation nearer its low. Which is the better fit depends on your goals.
| ABEO | SITM | |
|---|---|---|
Market Cap | $421.19M | $20.05B |
Sector | Health | Technology |
52-Week High | $7.45 | $901.60 |
52-Week Low | $4.17 | $212.77 |
Enterprise Value | $276.10M | $19.45B |
Trailing returns across standard periods
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →SiTime Corporation is a leading provider of MEMS-based silicon timing solutions used in various electronic applications. The company’s products, including oscillators, resonators, and clock ICs, are designed to replace traditional quartz-based timing devices, offering superior performance, reliability, and smaller size in harsh environments. SiTime's solutions are adopted across high-growth markets such as 5G, data centers, industrial IoT, and automotive, positioning the company as a key enabler for next-generation electronic systems.
Read more on SITM →